ABIONYX PHARMA: eps_diluted
| Value | {"amount": -0.12, "concept": "ifrs-full:DilutedEarningsLossPerShare"} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | current |
| Entity | ABIONYX PHARMA |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-23T23:53:14.801477+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/fcccddae-6901-4ff9-bc73-0fdedc7393cb
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:969500785J7VIC5YPC96:2023-12-31Retrieved: 2026-08-23T23:53:14.801477+02:00
Raw response sha256:
84cd09b5a9c076cfbfc26f8b51663071…Cite as: FACTANKER, https://factanker.com/fact/fcccddae-6901-4ff9-bc73-0fdedc7393cb
History
- no predecessors — first report